751 | GOLIDOCITINIB COMBINED WITH CHOP IN NEWLY‐DIAGNOSED PERIPHERAL T‐CELL LYMPHOMA: PRELIMINARY RESULTS FROM A PHASE 1/2 CLINICAL TRIAL

Documenti analoghi

• 165 | LINPERLISIB PLUS CHOP FOR NEWLY DIAGNOSED PERIPHERAL T‐CELL LYMPHOMA: A SINGLE‐ARM, OPEN‐LABLE, MULTI‐CENTER PHASE IB/II STUDY (LINCH TRIAL)
  di: Q. Cai, et al.
  Pubblicazione: (2025)
• 750 | GOLIDOCITINIB MONOTHERAPY IN THE TREATMENT OF REFRACTORY/RELAPSED INDOLENT T/NK‐CELL LYMPHOMA: PRELIMINARY RESULTS FROM T‐LGLL COHORT
  di: Y. Yu, et al.
  Pubblicazione: (2025)
• 332 | A MULTI‐CENTER PROSPECTIVE PHASE II CLINICAL TRIAL OF THE MEDZ‐R REGIMEN FOR THE TREATMENT OF NEWLY DIAGNOSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
  di: l. Zou, et al.
  Pubblicazione: (2025)
• 675 | A COMBINED EASIX‐IPI SCORE IMPROVES THE PROGNOSTIC STRATIFICATION OF NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA
  di: J. Y. Tan, et al.
  Pubblicazione: (2025)
• 62 | A PHASE II TRIAL OF PEMBROLIZUMAB CONCURRENT WITH RADIOTHERAPY FOR FRAIL PATIENTS WITH NEWLY DIAGNOSED EARLY‐STAGE NATURAL KILLER/T‐CELL LYMPHOMA (IELSG50)
  di: H. Zhong, et al.
  Pubblicazione: (2025)